NOT-AI-25-037: Notice of Early Expiration of PAR-23-300, "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)"

Notice of Early Expiration of PAR-23-300, "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)"

Notice Number:

NOT-AI-25-037

Key Dates

Release Date:

May 22, 2025

Related Announcements

September 12, 2023 - Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed). See NOFO PAR-23-300.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community that PAR-23-300, “Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed),” will be expired effective immediately. No further applications will be accepted for this notice of funding opportunity (NOFO).

Inquiries

Please direct all inquiries to:

Karobi Moitra, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-236-9703
Email: [email protected]